Hub genes with a high degree of connectivity, such as MYC, UBE2E2, MIB2, ANAPC1, TCEB1, CTLA4, and SPI1, might play important roles in the development of MetS, and could serve as potential biomarkers and therapeutic targets. Here, CTLA4 is linked to metabolic syndrome.